Table 3.
Residual tumour at re-TUR | Recurrence N (%) | Progression N (%) | CSM N (%) |
No residual tumour (267 patients) | 112 (41.9) | 38 (14.2) | 16 ( 6.0) |
Ta tumour (378 patients) | 193 (51.1) | 55 (14.6) | 31 ( 8.2) |
T1 tumour (289 patients) | 207 (71.6) | 73 (25.3) | 38 (13.1) |
Total (934 patients) | 512 (54.8) | 166 (17.8) | 85 (9.1) |
P value | P < 0.001 | P < 0.001 | P = 0.01 |